Table 2.
Additional Summary Statistics
Up-to-date with colorectal cancer screening |
P | Up-to-date with breast cancer screening |
P | |
---|---|---|---|---|
|
||||
Females [N=262,242] | ||||
Ever had false-positive breast cancer screening | ||||
No | 62.1% | <0.001 | 88.5% | <0.001 |
Repeat breast imaging within 91 d (no biopsy) | 68.8% | 95.0% | ||
Breast biopsy | 71.0% | 96.2% | ||
Ever had false-positive colorectal cancer screening | ||||
No | † | 90.1% | 0.75 | |
Positive FOBT (negative follow-up colonoscopy within 6 m, without biopsy/polypectomy)* | † | 90.3% | ||
Males [N=188,242] | ||||
Ever had false-positive prostate cancer screening | ||||
No | 62.7% | <0.001 | - | |
PSA ≥4.0 ng/mL (repeated within 91 d, no imaging/biopsy) | 70.4% | |||
Prostate imaging/biopsy | 75.9% |
We did not consider false-positives for patients who underwent initial colonoscopy because repeat screening would not be expected during the study period.
Repeat screening after a false-positive would not be expected during the study period.